Hb Miyano or alpha 41(C6)Thr----Ser: a new high oxygen affinity alpha chain variant found in an erythremic blood donor. 1989

Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
Department of Clinical Laboratory Science, Yamaguchi University School of Medicine, Ube, Japan.

An abnormal hemoglobin found in an erythremic blood donor was separable only by isoelectrofocusing, where it was located at the cathodic edge of Hb A. Cation exchange high performance liquid chromatography of a tryptic digest from the total alpha chain revealed splitting of the alpha T-6 peak, although our routine procedures failed to uncover the abnormality. This enabled the chemical characterization and quantitation of the abnormal hemoglobin as alpha 41(C6)Thr----Ser comprising about 30% of the total hemoglobin. The purified hemoglobin showed increased oxygen affinity, decreased subunit cooperativity and effect of organic phosphates, and normal Bohr effect.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
January 2013, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
November 1987, European journal of haematology,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
January 1992, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
January 1992, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
January 1987, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
January 1994, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
October 1993, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
January 1990, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
November 2001, Hemoglobin,
Y Ohba, and K Imai, and R Uenaka, and M Ami, and K Fujisawa, and K Itoh, and K Hirakawa, and T Miyaji
January 2009, Hemoglobin,
Copied contents to your clipboard!